Tricycloundecane compounds useful as modulators of nuclear hormone receptor function
US7550458B2 · kind B2 · utility
1Cited by
1References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 17, 2006 |
| Grant date | Jun 23, 2009 |
| Priority date | — |
| Expiry date | Dec 15, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/18
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Tricycloundecanes compounds, methods of using such compounds in the treatment of nuclear hormone receptor-associated conditions such as cancer and immune disorders, and pharmaceutical compositions containing such compounds are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.